Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Reduced expression of PDLIM4 gene correlates with good prognosis in acute myeloid leukemia.

Li Y, Qian J, Lin J, Qian W, Yang J, Chai HY, Wang CZ, Deng ZQ, Yao DM, Chen Q, Ma JC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1111-5. doi: 10.7534/j.issn.1009-2137.2013.05.005.

PMID:
24156416
2.

Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.

Zhou JD, Yang L, Zhang YY, Yang J, Wen XM, Guo H, Yao DM, Ma JC, Chen Q, Lin J, Qian J.

Med Oncol. 2015 Jan;32(1):386. doi: 10.1007/s12032-014-0386-9. Epub 2014 Nov 27.

PMID:
25428390
3.

[Expression of SALL4 gene in patients with acute and chronic myeloid leukemia].

Chen Q, Qian J, Lin J, Yang J, Li Y, Wang CZ, Chai HY, Chen XX, Qian Z, Ma JC, Zhang M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):315-9. doi: 10.7534/j.issn.1009-2137.2013.02.011. Chinese.

PMID:
23628023
4.

Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.

Tang CY, Lin J, Qian W, Yang J, Ma JC, Deng ZQ, Yang L, An C, Wen XM, Zhang YY, Qian J.

Clin Chem Lab Med. 2014 Dec;52(12):1843-50. doi: 10.1515/cclm-2014-0487.

PMID:
24955525
5.

Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.

Guo H, Lin J, Wen XM, Yang J, Qian W, Deng ZQ, Ma JC, Tang CY, An C, Liu Q, Zhou H, Qian J.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):4695-703. eCollection 2014.

6.

High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.

Zhou LY, Yin JY, Tang Q, Zhai LL, Zhang TJ, Wang YX, Yang DQ, Qian J, Lin J, Deng ZQ.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16073-80. eCollection 2015.

7.

Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.

Liu L, Chen R, Zhang Y, Fan W, Xiao F, Yan X.

Diagn Pathol. 2015 Jul 17;10:109. doi: 10.1186/s13000-015-0345-6.

8.

Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.

Zhou JD, Yang L, Zhu XW, Wen XM, Yang J, Guo H, Chen Q, Yao DM, Ma JC, Lin J, Qian J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5336-44. eCollection 2015.

9.

[Expression of NF-kappaB mRNA in acute myeloid leukemia].

Liu M, Wei XD, Lü XD, Fan RH, Yin QS, Zhou J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):359-62. Chinese.

PMID:
20416168
10.

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].

Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):98-103. Chinese.

PMID:
23611213
11.

BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.

Zhou JD, Yang J, Guo H, Deng ZQ, Wen XM, Yang L, Yin JY, Xiao GF, Lin J, Qian J.

Leuk Lymphoma. 2016;57(4):828-34. doi: 10.3109/10428194.2015.1088648. Epub 2015 Dec 23.

PMID:
26325005
12.

[Expression of Kindlins and angiopoietins in acute myeloid leukemia].

Wu WB, Zhang Q, Li Y, Shan SL, Li XY, Tian Z, Tang KJ, Wang M, Rao Q, Mi YC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Feb;20(1):7-11. Chinese.

PMID:
22391155
13.

[Expression of PRAME gene in acute leukemia and its clinical significance].

Zhu YL, Liu J, Zhu P, DU JW, Zhang Y, Gu JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1144-9. Chinese.

PMID:
18088454
14.

Clinical significance of reduced SFRP1 expression in acute myeloid leukemia.

An C, Guo H, Wen XM, Tang CY, Yang J, Zhu XW, Yin JY, Liu Q, Ma JC, Deng ZQ, Lin J, Qian J.

Leuk Lymphoma. 2015 Jul;56(7):2056-60. doi: 10.3109/10428194.2014.977883. Epub 2014 Nov 19.

PMID:
25347432
15.

[Expression and clinical significance of ID1 gene in acute myeloid leukemia].

Lu Y, Wang Q, Mu QT, Chen ZM, Lou JY, Ni WM, Jin J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Apr;33(4):278-81. Chinese.

PMID:
22781717
16.
17.

High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.

Am J Hematol. 2005 May;79(1):26-35.

18.

High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.

Yin JY, Tang Q, Zhai LL, Zhou LY, Qian J, Lin J, Wen XM, Zhou JD, Zhang YY, Zhu XW, Deng ZQ.

Tumour Biol. 2015 Dec;36(12):9711-6. doi: 10.1007/s13277-015-3731-5. Epub 2015 Jul 9.

PMID:
26152287
19.

[Quantification of GRAF gene expression in patients with acute myeloid leukemia using EvaGreen real time quantitative PCR].

Qian Z, Lin J, Qian J, Yao DM, Wang YL, Han LX, Zhu ZH, Xiao GF.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Jun;27(3):290-3. doi: 10.3760/cma.j.issn.1003-9406.2010.0.012. Chinese.

PMID:
20533268
20.

Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.

Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang L, Zhou JD, Deng ZQ, Wen XM, Guo H, Ma JC, Lin J, Qian J.

Clin Lab. 2016;62(1-2):113-20.

PMID:
27012040

Supplemental Content

Support Center